Preferred Label : Anti-CD19 CAR T Cells Preparation;
NCIt synonyms : CD19-targeting CAR-T Cells; Anti-CD19 CAR T Cell Preparation; Anti-CD19 CAR-T Cells; Anti-CD19 CAR T Cells; Anti-CD19 CAR-T-cells;
NCIt definition : Any preparation of CAR-T cells that targets CD19.;
NCI Metathesaurus CUI : CL1413433;
Origin ID : C176018;
UMLS CUI : C5854856;
Semantic type(s)
- Cell [UMLS semantic type]
- concept_is_in_subset
https://ansm.sante.fr/informations-de-securite/abecma-breyanzi-carvykti-kymriah-tecartus-et-yescarta-therapies-cellulaires-car-t-dirigees-contre-les-antigenes-cd19-ou-bcma-risque-de-tumeur-maligne-secondaire-issue-de-lymphocytes-t
2024
false
false
false
France
French
pharmacovigilance note
Secondary Malignant Neoplasm
Anti-CD19 CAR T Cells Preparation
Anti-BCMA CAR T Cells Preparation
Chimeric Antigen Receptor Therapy
lymphoma, T-Cell
continuity of patient care
hematologic neoplasms
leukemia, t-cell
Antineoplastic cell and gene therapy
---
https://www.has-sante.fr/jcms/p_3262259/fr/kymriah-ldgcb-tisagenlecleucel
2021
false
false
false
France
Anti-CD19 CAR T Cells Preparation
treatment outcome
insurance, health, reimbursement
tisagenlecleucel
adult
lymphoma, large B-Cell, diffuse
recurrence
infusions, intravenous
Recurrent Diffuse Large B-Cell Lymphoma
Refractory Diffuse Large B-Cell Lymphoma
evaluation of the transparency committee
tisagenlecleucel
receptors, antigen, t-cell
receptors, antigen, t-cell
---
